Advances in Molecular Characterization and Targeted Therapy in Dermatofibrosarcoma Protuberans
Figure 3
Images of advanced dermatofibrosarcoma protuberans of the supraclavicular region before and after therapy with imatinib, and after resection of residual disease. The patient is now 3 years free of disease.
